Precision medicine and data
Prenosis Sepsis ImmunoScore
FDA De Novo-authorized AI/ML software that assigns adult emergency department or hospital patients to sepsis risk categories within a clinician-reviewed workflow.
Last updated: June 5, 2026
Back to directoryTempus One medical AI product profile
Tempus generative AI assistant for querying clinical, molecular, imaging, EHR, and research data inside precision-medicine workflows.
Precision medicine and data
Best fit
Oncology and precision-medicine teams that need governed access to Tempus patient insights, test status, guideline context, trial matching, and multimodal data summaries.
- Primary use case
- Generative AI assistant for patient insight lookup, biomarker and report context, EHR workflow assistance, clinical trial search, documentation support, and multimodal research queries
- Audience
- Oncology clinicians, care teams, researchers, and health systems using Tempus Hub, EHR integrations, or Tempus data products
- Risk level
- High
- Pricing signal
- Enterprise, provider, EHR-integration, and life-sciences access terms vary; request current availability and contract terms.
- Official sources
- 6 official sources
Compare within workflow: Precision medicine and data · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Tempus One as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as high-risk precision-medicine decision support and workflow automation; separate clinical reference, documentation, prior authorization, trial matching, cohort research, and order-related use because each can carry different regulatory, contractual, and clinician-accountability obligations. |
|---|---|
| Privacy | Review Tempus privacy and compliance terms, customer agreements, EHR integration scope, PHI flows, support access, retention, audit logging, cross-product data use, and whether custom agents can access institution-specific procedures or repositories. |
| Evidence | Validate every guideline, biomarker, trial, patient-history, and cohort output against the underlying Tempus report, EHR note, guideline source, source excerpt, or research dataset before relying on it clinically. |
| Workflow | Best governed as clinician- or researcher-reviewed assistive infrastructure with local rules for source checking, note editing, prior-authorization review, trial-screening confirmation, patient communication, and custom-agent change control. |
Where Tempus One fits
Tempus describes Tempus One as a generative AI-enabled assistant for healthcare providers and researchers that can surface patient insights from clinical and molecular data, support EHR workflows, summarize histories and biomarkers, search trials, and process unstructured multimodal data; Tempus announcements also describe EHR integration, guideline access, documentation support, and custom agent-building capabilities.
Not for: Autonomous treatment selection, unsupervised patient communication, unsupported specialties, or use outside validated Tempus data, EHR, and institutional governance boundaries.
What to verify before using Tempus One
- Whether Tempus One is being used in Hub, an EHR integration, Lens, a provider workflow, or a life-sciences research workflow.
- Which patient data sources are connected: molecular reports, pathology, radiology, EHR notes, clinical guidelines, trial data, or research datasets.
- How ASCO guideline references, biomarker summaries, cohort queries, generated notes, prior-authorization drafts, and trial matches can be traced back to source evidence.
- BAA, PHI, consent, retention, audit logs, support access, model-training boundaries, and custom-agent controls for the specific deployment.
- Who reviews AI outputs before treatment planning, documentation, prior authorization, patient outreach, research analysis, or order changes.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- www.tempus.com / solutions / one
- www.tempus.com / life-sciences / tempus-one
- www.tempus.com / news / introducing-tempus-one-in-the-ehr-with-integrated-guidelines
- investors.tempus.com / news-releases / news-release-details
- www.tempus.com / privacy-policy
- www.tempus.com / tempus-privacy-and-compliance-policies
Related medical AI products
Precision medicine and data
Anumana ECG-AI
Cardiovascular AI platform using standard 12-lead ECGs to surface signals such as low ejection fraction, pulmonary hypertension, and cardiac amyloidosis for clinician follow-up.
Precision medicine and data
Eko Health SENSORA
FDA-cleared cardiovascular detection platform that pairs Eko digital stethoscopes with AI-supported ECG and heart-sound analysis for supervised point-of-care screening.
Precision medicine and data
AliveCor Kardia 12L
Portable AI-powered 12-lead ECG system that uses a reduced leadset and KAI 12L algorithms to support clinician-reviewed cardiac determinations.